Free shipping on all orders over $ 500

CPI-1205

Cat. No. M9936

All AbMole products are for research use only, cannot be used for human consumption.

CPI-1205 Structure
Synonym:

Lirametostat; CPI1205

Size Price Availability Quantity
2mg USD 140  USD140 In stock
5mg USD 240  USD240 In stock
10mg USD 360  USD360 In stock
25mg USD 540  USD540 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

CPI-1205 (Lirametostat) is a highly potent (biochemical IC50 = 0.002 μM, cellular EC50 = 0.032 μM) and selective inhibitor of EZH2. CPI-1205 has IC50 values of 2 nM and 52 nM for EZH2 and EZH1, respectively. CPI-1205 selectively inhibits the activity of both wild-type and mutated forms of EZH2, this specifically prevents the methylation of histone H3 on lysine 27 (H3K27). Decrease in histone methylation alters gene expression patterns associated with cancer pathways and results in decreased proliferation of EZH2-expressing cancer cells.

Chemical Information
Molecular Weight 518.57
Formula C27H33F3N4O3
CAS Number 1621862-70-1
Solubility (25°C) DMSO ≥ 80 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Related EZH2 Products
GSK126

GSK126 is a potent, highly selective, S-adenosyl-methionine-competitive, small-molecule inhibitor of EZH2 methyltransferase activity.

EPZ005687

EPZ005687 is a potent, selective EZH2 inhibitor,Ki The value is 24 nM, which is 50 times more selective than EZH1 and 500 times more selective than 15 other methyltransferases.

GSK343

GSK343 is a potent and selective EZH2 inhibitor with IC50 of 4 nM, showing 60 fold selectivity against EZH1, and >1000 fold selectivity against other histone methyltransferases.

UNC1999

UNC1999 is a potent, orally bioavailable and selective inhibitor of EZH2 and EZH1 with IC50 of 2 nM and 45 nM, respectively, showing >1000-fold selectivity over a broad range of epigenetic and non-epigenetic targets.

CPI-169 racemate

CPI-169 racemate is the racemate form of CPI-169, which is a novel and potent EZH2 inhibitor with IC50 <1 nM(inhibition of the catalytic activity of PRC2); decreases cellular levels of H3K27me3 with an EC50 of 70 nM, and triggers cell cycle arrest and apoptosis in a variety of cell lines.

  Catalog
Abmole Inhibitor Catalog




Keywords: CPI-1205, Lirametostat; CPI1205 supplier, EZH2, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.